Drug Safety Labeling Changes - May  2012

Email bookmark
Font : A-A+

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

  • C - Contraindications
  • W - Warnings
  • P - Precautions
  • AR - Adverse Reactions

Drug Name Sections Modified
C W P AR
Abobotulinumtoxin A Injection - - - -
Adalimumab - - -
Albuterol and Ipratropium - - -
Alefacept - - -
Benazepril -
Bevacizumab - - -
Chlorascrub Swabsticks - - -
Chlorhexidine - - -
Chlorhexidine - - -
Chlorhexidine - - -
Clarithromycin - -
Clonidine - -
Daptomycin - - -
Denosumab - - -
Dexlansoprazole - -
Dexmethylphenidate hcl - -
Estradiol -
Ethosuximide -
Filgrastim - - -
Fingolimod
Insulin Detemir - -
Iopromide -
Iopromide - - - -
Lansoprazole - -
Lenalidomide - - - -
Linagliptin - -
Lisinopril - - -
Lisinopril and Hydrochlorothiazide - - -
Omeprazole and Sodium Bicarbonate - -
Pamidronate -
Pantoprazole - -
Pioglitazone and Metformin -
Pralatrexate Solution -
Rabeprazole - -
Ulipristal Acetate - - -
Ustekinumab - -
Venlafaxine - - -

2016 - Monthly Summary Report for Drug Label Changes

2015 - Monthly Summary Report for Drug Label Changes

2014 - Monthly Summary Report for Drug Label Changes

2013 - Monthly Summary Report for Drug Label Changes

2012 - Monthly Summary Report for Drug Label Changes

Buy Medication (Drug) at Concessional Price from India

Drugs A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Drugs Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook